Clinical Effect of Captopril Combined With Nasal Continuous Positive Airway Pressure Ventilation in Treating Congenital Heart Disease Children Complicated With Pneumonia and Heart Failure
Yu-xiao CHEN,Kan ZHU
DOI: https://doi.org/10.3969/j.issn.1008-5971.2016.06.025
2016-01-01
Abstract:Objective To observe the clinical effect of captopril combined with nasal continuous positive airway pressure ventilation in treating congenital heart disease children complicated with pneumonia and heart failure. Methods A total of 120 congenital heart disease children complicated with pneumonia and heart failure were selected in Wuxi People's Hospital Affiliated to Nanjing Medical University from May 2013 to March 2015,and they were divided into A group,B group and C group according to random number table,each of 40 cases. Children of A group received oxygen inhalation by nasal tube or mask, children of B group received nasal continuous positive airway pressure ventilation,while patients of C group received captopril combined with nasal continuous positive airway pressure ventilation; all of the three groups continuously treated for 2 weeks. Remission time of symptoms, index of pulmonary function ( including FVC, FEV1 , FEV1 / FVC, MMEF, PEF, PaCO2 ,PaO2 and SaO2 ), index of cardiac function ( including SV, LVFS, LVEF, NT-proBNP, cTnI ) and serum inflammatory cytokines( including IL-6,hs-CRP and TNF-α) levels before and after treatment,and incidence of adverse reactions/ complications were compared among the three groups. Results Recovery time of heart rate,disappearance time of lung wet rale and improvement time of breath of C group were statistically significantly shorter than those of A group and B group (P ﹤ 0. 05);recovery time of heart rate,disappearance time of lung wet rale and improvement time of breath of B group were statistically significantly shorter than those of A group( P ﹤ 0. 05). No statistically significant differences of FVC,FEV1 , FEV1 / FVC,MMEF,PEF,PaCO2 ,PaO2 or SaO2 was found among the three groups before treatment( P ﹥ 0. 05);after treatment,FVC,FEV1 ,FEV1 / FVC,MMEF,PEF,PaO2 and SaO2 of C group were statistically significantly higher than those of A group and B group,while PaCO2 of C group was statistically significantly lower than that of A group and B group, respectively(P ﹤ 0. 05). No statistically significant differences of SV,LVPS,LVEF,NT-proBNP or cTnI was found among the three groups before treatment(P ﹥ 0. 05);after treatment,SV,LVPS and LVEF of C group were statistically significantly higher than those of A group and B group,while NT-proBNP and cTnI of C group were statistically significantly lower than those of A group and B group after treatment(P ﹤ 0. 05). No statistically significant differences of serum level of IL-6,hs-CRP or TNF-α was found among the three groups before treatment(P ﹥ 0. 05),while serum levels of IL-6,hs-CRP and TNF-α of C group were statistically significantly lower than those of A group and B group(P ﹤ 0. 05). No one of the two groups occurred any severe adverse reactions/ complications. Conclusion Captopril combined with nasal continuous positive airway pressure ventilation has certain clinical effect in treating congenital heart disease children complicated with pneumonia and heart failure, can effectively relive the clinical symptoms,improve the cardiac function and pulmonary function,reduce the serum inflammatory cytokines levels,and is relatively safe.